CA3103433A1 - Nouveau virus de poisson - Google Patents
Nouveau virus de poisson Download PDFInfo
- Publication number
- CA3103433A1 CA3103433A1 CA3103433A CA3103433A CA3103433A1 CA 3103433 A1 CA3103433 A1 CA 3103433A1 CA 3103433 A CA3103433 A CA 3103433A CA 3103433 A CA3103433 A CA 3103433A CA 3103433 A1 CA3103433 A1 CA 3103433A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- sequences
- virus
- sequence
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Polymers & Plastics (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Plant Pathology (AREA)
- Marine Sciences & Fisheries (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention concerne un nouveau virus de poisson, un acide nucléique isolé présentant une séquence choisie dans le groupe constitué par SEQ ID NO : 2 et 3, des séquences étant complémentaires de SEQ ID NO : 2 et 3, et des variants de celui-ci étant au moins 70 % identiques à celui-ci. Un procédé de détection de l'acide nucléique, des amorces, des sondes, un vecteur et une cellule hôte, un vaccin à ADN, une protéine recombinante, un vaccin recombinant, un anticorps et un nécessaire de diagnostic sont en outre décrits.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20180836 | 2018-06-15 | ||
NO20180836A NO344698B1 (en) | 2018-06-15 | 2018-06-15 | Novel fish virus |
PCT/NO2019/050124 WO2019240596A1 (fr) | 2018-06-15 | 2019-06-14 | Nouveau virus de poisson |
Publications (1)
Publication Number | Publication Date |
---|---|
CA3103433A1 true CA3103433A1 (fr) | 2019-12-19 |
Family
ID=67211790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA3103433A Pending CA3103433A1 (fr) | 2018-06-15 | 2019-06-14 | Nouveau virus de poisson |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3807403A1 (fr) |
CA (1) | CA3103433A1 (fr) |
CL (1) | CL2020003238A1 (fr) |
NO (1) | NO344698B1 (fr) |
WO (1) | WO2019240596A1 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2464338C (fr) * | 2001-10-19 | 2014-12-02 | Akzo Nobel Nv | Vaccin contre le virus de l'anemie infectieuse du saumon |
JP2006507841A (ja) * | 2002-11-14 | 2006-03-09 | ダーマコン, インコーポレイテッド | 機能的siRNAおよび超機能的siRNA |
US9002652B1 (en) * | 2005-01-27 | 2015-04-07 | Institute For Systems Biology | Methods for identifying and using organ-specific proteins in blood |
NO2640832T3 (fr) * | 2010-11-15 | 2018-05-19 | ||
WO2016075277A1 (fr) * | 2014-11-14 | 2016-05-19 | Patogen Analyse As | Nouveau virus de poisson et méthode de détection |
-
2018
- 2018-06-15 NO NO20180836A patent/NO344698B1/en unknown
-
2019
- 2019-06-14 CA CA3103433A patent/CA3103433A1/fr active Pending
- 2019-06-14 WO PCT/NO2019/050124 patent/WO2019240596A1/fr active Application Filing
- 2019-06-14 EP EP19737262.6A patent/EP3807403A1/fr active Pending
-
2020
- 2020-12-14 CL CL2020003238A patent/CL2020003238A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
NO20180836A1 (en) | 2019-12-16 |
WO2019240596A1 (fr) | 2019-12-19 |
EP3807403A1 (fr) | 2021-04-21 |
NO344698B1 (en) | 2020-03-09 |
CL2020003238A1 (es) | 2021-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bumbarov et al. | Characterization of bluetongue virus serotype 28 | |
Sivakumar et al. | Evolution and genetic diversity of Theileria | |
Clark et al. | Eimeria species parasites as novel vaccine delivery vectors: anti-Campylobacter jejuni protective immunity induced by Eimeria tenella-delivered CjaA | |
DK181370B1 (en) | Primer, method and diagnostic kit for use in the detection of the presence of lumpfish flavivirus | |
JP2009077713A (ja) | アイメリア・マキシマ(Eimeriamaxima)の配偶子母細胞由来の組換え56及び82kDa各抗原をコードする核酸及びその使用 | |
Goldenberg et al. | Optimized polypeptide for a subunit vaccine against avian reovirus | |
CN113943714A (zh) | 一种猫杯状病毒毒株及其应用 | |
Watanabe et al. | Evaluation of the protective effects of DNA vaccines encoding an infection-related cysteine protease from Cryptocaryon irritans, the pathogenic organism of cryptocaryoniasis | |
Jang et al. | Efficacy of formalin-killed Pseudomonas anguilliseptica vaccine on immune gene expression and protection in farmed olive flounder, Paralichthys olivaceus | |
Avendaño et al. | Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides’ immunogenicity and in vitro seroneutralisation capability | |
NO20170739A1 (en) | Novel virus in Fish and Method for detection | |
CA3103433A1 (fr) | Nouveau virus de poisson | |
KR20150110531A (ko) | Ibv, csfv 및 ndv 의 고 해상도 용융 유전자형분석 | |
US10294483B2 (en) | Eimeria tenella elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis | |
Omony et al. | Immunogenicity and protection efficacy evaluation of avian paramyxovirus serotype-1 (APMV-1) isolates in experimentally infected chickens | |
CA2986834C (fr) | Bacterie piscirickettsia salmonis attenuee | |
NO20201187A1 (en) | Novel fish virus | |
Molad et al. | Differentiation between Israeli B. bovis vaccine strain and field isolates | |
RU2813731C2 (ru) | Новый коронавирус рыб | |
Saeed et al. | Molecular Detection of Outer Membrane Protein 2 Gene in Isolated Brucella from Sheep and Goats in Sharazor/Kurdistan Region of Iraq. | |
WO2010112935A1 (fr) | Test de diagnostic pour virus | |
JP2007082496A (ja) | ヒラメのインターフェロン | |
Chelliah | Immunogenicity of Recombinant HS ABA392 DNA Vaccine Against Haemorrhagic Septicaemia In Animal Model | |
CN111420041A (zh) | 水产病原菌糖酵解途径中持家酶的广谱组合型疫苗及其应用 | |
TW201422814A (zh) | 針對海產魚之類結節症之dna疫苗 |